DG Health Maximum Strength Pain Relieving Cleansing Benzalkonium Cl, Lidocaine HCl 1.3 mg/mL; 40 mg/mL Spray, 148 mL — NDC 75712-200-01 (Billing 75712-0200-01)
This is a package of 148 mL of DG Health Maximum Strength Pain Relieving Cleansing Benzalkonium Cl, Lidocaine HCl 1.3 mg/mL; 40 mg/mL Spray from Dollar General Corporation, marketed since Feb 2022 and currently FDA-listed. It is this product's only package size.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 2047877
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Quaternary ammonium compounds class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
This is a topical spray product marketed as an OTC monograph drug containing benzalkonium chloride and lidocaine hydrochloride. Benzalkonium chloride is an antimicrobial agent typically used in cleansing and antiseptic products to help reduce bacteria on the skin. Lidocaine hydrochloride is a local anesthetic commonly used in topical products to provide temporary numbing or pain relief at the application site. Together, these ingredients are typically used in products intended to cleanse and provide localized pain relief.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 2, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 75712-0200-01 You're viewing this Main listing | 148 mL in 1 BOTTLE | 2022-02-11 | — | Active |
Therapeutic equivalents
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses first aid to help prevent bacterial contamination or skin infection, and for temporary relief of pain and itching associated with minor: cuts scrapes burns sunburn skin irritations
⏱️ Dosage and Administration ▾
Directions adults and children 2 years and older: clean the affected area; spray a small amount on the area 1-3 times daily; may be covered with a sterile bandage (let dry first) children under 2 years: ask a doctor
⚠️ Warnings ▾
Warnings For external use only Ask a doctor before use if you have deep or puncture wounds animal bites serious burns When using this product do not use in or near the eyes do not apply over large areas of the body or in large quantities do not apply over raw surfaces or blistered areas Stop use and ask a doctor if condition worsens symptoms persist for more than 7 days, or clear up and occur again within a few days
🧪 Active Ingredient ▾
Active ingredients Benzalkonium Cl 0.13% Lidocaine HCl 4%
🧪 Inactive Ingredients ▾
Inactive ingredients chlorphenesin, edetate disodium, fragrance, glycerin, nonoxynol 9, phenoxyethanol, propylene glycol, purified water
🎯 Purpose ▾
Purpose Benzalkonium Cl – First Aid Antiseptic Lidocaine HCl – Pain Relieving Spray
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have deep or puncture wounds animal bites serious burns
📄 When Using This Product ▾
When using this product do not use in or near the eyes do not apply over large areas of the body or in large quantities do not apply over raw surfaces or blistered areas
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if condition worsens symptoms persist for more than 7 days, or clear up and occur again within a few days
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Other Information ▾
Other Safety Information store at room temperature avoid excessive heat
📄 Questions or Comments ▾
Questions 888-309-9030
📄 Package Label / Principal Display Panel ▾
Package/Label Principal Display Panel Label Front
Principal Display Panel Label Back
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |